"COS Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen (ANTIGENS, POLYOMAVIRUS TRANSFORMING). They are used for transfection and cloning. (The CV-1 cell line was derived from the kidney of an adult male African green monkey (CERCOPITHECUS AETHIOPS).)
Descriptor ID |
D019556
|
MeSH Number(s) |
A11.251.210.172.500 A11.329.228.220
|
Concept/Terms |
COS Cells- COS Cells
- COS Cell
- Cell, COS
- Cells, COS
COS-7 Cells- COS-7 Cells
- COS 7 Cells
- COS-7 Cell
- Cell, COS-7
- Cells, COS-7
COS-1 Cells- COS-1 Cells
- COS 1 Cells
- COS-1 Cell
- Cell, COS-1
- Cells, COS-1
|
Below are MeSH descriptors whose meaning is more general than "COS Cells".
Below are MeSH descriptors whose meaning is more specific than "COS Cells".
This graph shows the total number of publications written about "COS Cells" by people in this website by year, and whether "COS Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 4 | 4 |
2001 | 0 | 1 | 1 |
2002 | 0 | 2 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 5 | 5 |
2005 | 0 | 7 | 7 |
2006 | 0 | 3 | 3 |
2007 | 0 | 5 | 5 |
2009 | 0 | 3 | 3 |
2010 | 0 | 2 | 2 |
2011 | 0 | 9 | 9 |
2012 | 0 | 1 | 1 |
2013 | 0 | 3 | 3 |
2015 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "COS Cells" by people in Profiles.
-
Valm AM, Cohen S, Legant WR, Melunis J, Hershberg U, Wait E, Cohen AR, Davidson MW, Betzig E, Lippincott-Schwartz J. Applying systems-level spectral imaging and analysis to reveal the organelle interactome. Nature. 2017 06 01; 546(7656):162-167.
-
Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K. Altering the Proteoglycan State of Transforming Growth Factor ? Type III Receptor (T?RIII)/Betaglycan Modulates Canonical Wnt/?-Catenin Signaling. J Biol Chem. 2016 Dec 02; 291(49):25716-25728.
-
Ali YO, Allen HM, Yu L, Li-Kroeger D, Bakhshizadehmahmoudi D, Hatcher A, McCabe C, Xu J, Bjorklund N, Taglialatela G, Bennett DA, De Jager PL, Shulman JM, Bellen HJ, Lu HC. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
-
Meghdari M, Gao N, Abdullahi A, Stokes E, Calhoun DH. Carboxyl-terminal truncations alter the activity of the human a-galactosidase A. PLoS One. 2015; 10(2):e0118341.
-
Costantini L, Snapp E. Probing endoplasmic reticulum dynamics using fluorescence imaging and photobleaching techniques. Curr Protoc Cell Biol. 2013 Sep 24; 60:21.7.1-21.7.29.
-
Heckler EJ, Crassous PA, Baskaran P, Beuve A. Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity. Biochem J. 2013 May 15; 452(1):161-9.
-
Yudowski GA, Olsen O, Adesnik H, Marek KW, Bredt DS. Acute inactivation of PSD-95 destabilizes AMPA receptors at hippocampal synapses. PLoS One. 2013; 8(1):e53965.
-
Gawecka JE, Geerts D, Koster J, Caliva MJ, Sulzmaier FJ, Opoku-Ansah J, Wada RK, Bachmann AS, Ramos JW. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer. 2012 Oct 01; 131(7):1556-68.
-
Qin Y, Xu J, Aysola K, Begum N, Reddy V, Chai Y, Grizzle WE, Partridge EE, Reddy ES, Rao VN. Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. J Cell Physiol. 2011 Dec; 226(12):3355-67.
-
Baskaran P, Heckler EJ, van den Akker F, Beuve A. Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity. PLoS One. 2011; 6(11):e26976.